InfuSystems (INFU) vs Orthofix Medical (OFIX)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.
Summary
InfuSystems (INFU) has outperformed Orthofix Medical (OFIX) over the past year, gaining 51.7% versus a loss of 60.2%. Over five years, INFU leads with a -15.9% price change compared with -80.6% for OFIX. InfuSystems is the larger company by market cap ($287.5 million vs $247.4 million), about 1.2 times the size.
On valuation, InfuSystems trades at a lower forward P/E (25.6x vs 33.7x for Orthofix Medical). InfuSystems converts more of its revenue into profit, with a net margin of 4.6% versus -11.2%.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | INFU | OFIX |
|---|---|---|
| Share price | $14.35 | $6.07 |
| Market cap | $287.48M | $247.41M |
| 1-day change | +2.06% | -4.26% |
| YTD return | +59.98% | -59.96% |
| 1-year return | +51.69% | -60.22% |
| 5-year return | -15.93% | -80.64% |
| P/E ratio (TTM) | 32.61 | — |
| Forward P/E | 25.63 | 33.72 |
| EPS (TTM) | $0.44 | $-1.10 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| Revenue (latest FY) | $143.44M | $822.31M |
| Revenue growth (YoY) | +6.36% | +2.85% |
| Net income (latest FY) | $6.63M | $-92.19M |
| Gross margin | 55.98% | 68.83% |
| Operating margin | 8.31% | -9.90% |
| Net margin | 4.62% | -11.21% |
| 52-week high | $15.47 | $16.42 |
| 52-week low | $7.29 | $6.04 |
| Distance from 52-week high | -7.24% | -63.03% |
| Analyst consensus | strong_buy | buy |
| Avg. price target upside | +28.92% | +64.74% |
| Average volume | 136.60K | 481.16K |
| Shares outstanding | 20.03M | 40.76M |
| Employees | 461 | 1,605 |
| Sector | Health Care | Health Care |
| Industry | Medical/Dental Instruments | Medical/Dental Instruments |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- INFU has outperformed OFIX by 111.9 percentage points over the past year.
- InfuSystems is more profitable, keeping 4.6 cents of every revenue dollar as net income versus -11.2 cents for Orthofix Medical.
About InfuSystems
INFU stock →InfuSystem Holdings, Inc., through its subsidiaries, provides infusion pumps and related products and services in the United States and Canada. It operates through two segments: Patient Services and Device Solutions.
Health Care · Medical/Dental Instruments · 461 employees
About Orthofix Medical
OFIX stock →Orthofix Medical Inc., together with its subsidiaries, operates as a medical technology company in the United States, Italy, the United Kingdom, France, Germany, Brazil, and internationally. It operates through two segments, Global Spine and Global Limb Reconstruction.
Health Care · Medical/Dental Instruments · 1,605 employees
INFU vs OFIX FAQ
Which is bigger, InfuSystems or Orthofix Medical?
InfuSystems (INFU) is larger, with a market capitalization of $287.48M compared with $247.41M for Orthofix Medical (OFIX).
Which stock has performed better over the past year, INFU or OFIX?
INFU returned +51.69% over the past 12 months, compared with -60.22% for OFIX (price return, excluding dividends). Past performance does not predict future results.
Are InfuSystems and Orthofix Medical in the same industry?
Yes. Both are classified in the Medical/Dental Instruments industry within the Health Care sector.